Background and study aims: Colonoscopy and guaiac-based fecal occult blood tests (FOBT) are recommended and offered for colorectal cancer (CRC) screening in Germany. We aimed to explore their utilization in a large insurance-based cohort.
Patients and methods: Claims data from between 2000 and 2008 were collected for 170 493 individuals who were insured by a large health insurance plan in the federal state of Hesse, Germany. The percentages of individuals who had recently utilized CRC screening-related procedures were calculated. Additionally, multiple test use and identification of CRC screening providers were ascertained.
Results: Following the inception of the current CRC screening program in 2002, colonoscopy utilization rates varied only slightly and FOBT use decreased in individuals aged ≥ 50 years. At the end of 2008, the age-standardized percentages of individuals who had undergone colonoscopy within ≤ 10 years were 23 % for men and 26 % for women. The proportions of individuals who had used FOBT within ≤ 1 year were 14 % for men and 22 % for women. Patient education had been utilized by 38 % of eligible persons and was increasingly followed by screening colonoscopy. For women, practices that specialized in gynecology were the main providers of FOBT (93 %) and patient education (61 %).
Conclusions: This study provides new insights into the inter-related utilization of colonoscopy, FOBT, and patient education in Germany, and may be particularly informative for the design of strategies to increase CRC screening uptake. It indicates that sex differences in CRC screening test use could result to a large extent from general visits to different types of specialist physicians involved in the CRC screening process.
Appendix (online only)The following material is available online
3
Arditi C, Peytremann-Bridevaux I, Burnand B et al.
Appropriateness of colonoscopy in Europe (EPAGE II) – screening for colorectal cancer.
Endoscopy.
2009;
41
200-208
4
Hewitson P, Glasziou P, Watson E et al.
Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update.
Am J Gastroenterol.
2008;
103
1541-1549
6
Lansdorp-Vogelaar I, Knudsen A B, Brenner H.
Cost-effectiveness of colorectal cancer screening – an overview.
Best Pract Res Clin Gastroenterol.
2010;
24
439-449
7
Schmiegel W, Pox C, Reinacher-Schick A et al.
S3 guidelines for colorectal carcinoma.
Results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII).
Z Gastroenterol.
2010;
48
65-136
9
von der Schulenburg J M, Prenzler A, Schurer W.
Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer.
Eur J Health Econ.
2010;
10
21-26
10 Gemeinsamer Bundesausschuss [Federal Joint Committee]. Richtlinie über die Früherkennung von Krebserkrankungen. [Guideline on early detection of cancers] (in German only). 2010
Available from: http://www.g-ba.de/ Accessed: 6 October 2010
11 Kassenärztliche Bundesvereinigung (KBV) [National Association of Statutory Health Insurance Physicians]. Voraussetzungen gemäß § 135 Abs. 2 SGB V zur Ausführung und Abrechnung von koloskopischen Leistungen. (Qualitätssicherungsvereinbarung zur Koloskopie) [quality assurance directive concerning colonoscopy], as of 24 July 2006. Document number: 1 003 739 016. Available from: http://daris.kbv.de Accessed: 6 October 2010
12
Sieverding M, Matterne U, Ciccarello L.
Gender differences in FOBT use: evidence from a large German survey.
Z Gastroenterol.
2008;
46 Suppl 1
47-51
13
Wuppermann D, Wuppermann U, Riemann J F.
[Actual state of knowledge of the German population about the early detection of colorectal cancer – a study by the ‘Stiftung LebensBlicke’ in cooperation with the institute for demoscopy in Allensbach].
Z Gastroenterol.
2009;
47
1132-1136
14
Sieverding M, Matterne U, Ciccarello L, Haug U.
Colonoscopy use in a country with a long-standing colorectal cancer screening programme: evidence from a large German survey.
Z Gastroenterol.
2010;
48
1351-1357
15
Stock C, Brenner H.
Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE).
Endoscopy.
2010;
42
546-556
16 Altenhofen L, Heringer M, Blaschy S et al. 6. Jahresbericht ‘Projekt wissenschaftliche Begleitung von Früherkennungs-Koloskopien in Deutschland’. [6th annual report ‘Project scientific monitoring of screening colonoscopy in Germany’] (in German only). Available from: http://www.zi-berlin.de/ Accessed: 6 October 2010
17
Stock C, Haug U, Brenner H.
Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: review and analysis of recent trends.
Gastrointest Endosc.
2010;
71
366-381
18
Centers for Disease Control and Prevention (CDC) .
Vital signs: colorectal cancer screening among adults aged 50 – 75 years – United States, 2008.
MMWR Morb Mortal Wkly Rep.
2010;
59
808-812
19
Ihle P, Köster I, Herholz H et al.
Versichertenstichprobe AOK Hessen/KV Hessen – Konzeption und Umsetzung einer personenbezogenen Datenbasis aus der Gesetzlichen Krankenversicherung. [Statutory Health Insurance Sample AOK Hesse/KV Hesse – concept and implementation of a person related database].
Gesundheitswesen.
2005;
67
638-645
20 Busse R, Riesberg A. Health care systems in transition: Germany. Copenhagen: WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies; 2004
Available from: http://www.euro.who.int/ Accessed: 6 October 2010
21 Kassenärztliche Bundesvereinigung (KBV) [National Association of Statutory Health Insurance Physicians]. Einheitlicher Bewertungsmaßstab (EBM).
Available from: http://www.kbv.de/8156.html Accessed: 6 October 2010
22 German Institute of Medical Documentation and Information (DIMDI) .Operations- und Prozedurenschlüssel (OPS).
Available from: http://www.dimdi.de/static/en/ Accessed: 6 October 2010
23
van Rossum L G, van Rijn A F, Laheij R J et al.
Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
Gastroenterology.
2008;
135
82-90
24
Steele R JC, McClements P L, Libby G et al.
Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer.
Gut.
2009;
58
530-535
28
McQueen A, Bartholomew L, Greisinger A et al.
Behind closed doors: physician-patient discussions about colorectal cancer screening.
J Gen Intern Med.
2009;
24
1228-1235
29
Lafata J E, Divine G, Moon C, Williams L K.
Patient-physician colorectal cancer screening discussions and screening use.
Am J Prev Med.
2006;
31
202-209
30
Ling B S, Trauth J M, Fine M J et al.
Informed decision-making and colorectal cancer screening: is it occurring in primary care?.
Med Care.
2008;
46
S23-29
32
Zajac I T, Whibley A H, Cole S R et al.
Endorsement by the primary care practitioner consistently improves participation in screening for colorectal cancer: a longitudinal analysis.
J Med Screen.
2010;
17
19-24
33
Ziegler M, Schubring-Giese B, Bühner M, Kolligs F T.
Attitude to secondary prevention and concerns about colonoscopy are independent predictors of acceptance of screening colonoscopy.
Digestion.
2010;
81
120-126
34
Beydoun H, Beydoun M.
Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States.
Cancer Causes Control.
2008;
19
339-359
35
Heitman S J, Ronksley P E, Hilsden R J et al.
Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis.
Clin Gastroenterol Hepatol.
2009;
7
1272-1278
38
Robb K, Power E, Kralj-Hans I et al.
Flexible sigmoidoscopy screening for colorectal cancer: uptake in a population-based pilot programme.
J Med Screen.
2010;
17
75-78
40
Anhang Price R, Zapka J, Edwards H, Taplin S H.
Organizational factors and the cancer screening process.
J Natl Cancer Inst Monogr.
2010;
2010
38-57
41
Farraye F A, Wong M, Hurwitz S et al.
Barriers to endoscopic colorectal cancer screening: are women different from men?.
Am J Gastroenterol.
2004;
99
341-349
42
McQueen A, Vernon S W, Meissner H I et al.
Are there gender differences in colorectal cancer test use prevalence and correlates?.
Cancer Epidemiol Biomarkers Prev.
2006;
15
782-791
43
Friedemann-Sanchez G, Griffin J, Partin M.
Gender differences in colorectal cancer screening barriers and information needs.
Health Expectations.
2007;
10
148-160
44
Holden D J, Jonas D E, Porterfield D S et al.
Systematic review: enhancing the use and quality of colorectal cancer screening.
Ann Intern Med.
2010;
152
668-676
45
von Euler-Chelpin M, Brasso K, Lynge E.
Determinants of participation in colorectal cancer screening with faecal occult blood testing.
J Public Health (Oxf).
2010;
32
395-405
47
Hullegie P, Klein T J.
The effect of private health insurance on medical care utilization and self-assessed health in Germany.
Health Econ.
2010;
19
1048-1062
48
Razum O, Altenhöner T, Breckenkamp J, Voigtländer S.
Social epidemiology after the German reunification: east vs. west or poor vs. rich?.
Int J Public Health.
2008;
53
13-22
